5SAV
DDR1, N-[2-[3-(2-aminopyrimidin-5-yl)oxyphenyl]ethyl]-3-(trifluoromethoxy)benzamide, 1.760A, P212121, Rfree=23.5%
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SLS BEAMLINE X10SA |
Synchrotron site | SLS |
Beamline | X10SA |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2013-12-12 |
Detector | PSI PILATUS 6M |
Wavelength(s) | 1.00000 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 44.000, 62.560, 109.280 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 41.153 - 1.760 |
R-factor | 0.1947 |
Rwork | 0.193 |
R-free | 0.23460 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | inhouse model |
RMSD bond length | 0.007 |
RMSD bond angle | 1.118 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | PHENIX (dev_1539) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 41.150 | 41.153 | 1.810 |
High resolution limit [Å] | 1.760 | 7.870 | 1.760 |
Rmerge | 0.208 | 0.042 | 2.028 |
Rmeas | 0.230 | 0.046 | 2.198 |
Total number of observations | 199573 | ||
Number of reflections | 30720 | 412 | 2222 |
<I/σ(I)> | 6.74 | 27.78 | 0.89 |
Completeness [%] | 99.9 | 98.6 | 100 |
Redundancy | 6.55 | 5.527 | 6.74 |
CC(1/2) | 0.994 | 0.998 | 0.288 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 6.5 | 293 | 7.6 mg/mL protein in 20mM HEPES/NaOH pH7.5, 5mM DTT, 5% glycerol, 0.1M NaCl mixed with reservoir consisting of 0.1M MES/NaOH pH 6.5, 0.2M KI, 25% PEG 4000 |